IL160451A0 - 17 alpha-hydroxy-14beta-steroids with hormonal effect - Google Patents

17 alpha-hydroxy-14beta-steroids with hormonal effect

Info

Publication number
IL160451A0
IL160451A0 IL16045102A IL16045102A IL160451A0 IL 160451 A0 IL160451 A0 IL 160451A0 IL 16045102 A IL16045102 A IL 16045102A IL 16045102 A IL16045102 A IL 16045102A IL 160451 A0 IL160451 A0 IL 160451A0
Authority
IL
Israel
Prior art keywords
14beta
steroids
alpha
hydroxy
hormonal effect
Prior art date
Application number
IL16045102A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL160451(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL160451A0 publication Critical patent/IL160451A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16045102A 2001-09-12 2002-09-06 17 alpha-hydroxy-14beta-steroids with hormonal effect IL160451A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (1)

Publication Number Publication Date
IL160451A0 true IL160451A0 (en) 2004-07-25

Family

ID=8180920

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16045102A IL160451A0 (en) 2001-09-12 2002-09-06 17 alpha-hydroxy-14beta-steroids with hormonal effect
IL160451A IL160451A (en) 2001-09-12 2004-02-18 17 Alpha-hydroxy-14 in cell-steroids that have a hormonal effect

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160451A IL160451A (en) 2001-09-12 2004-02-18 17 Alpha-hydroxy-14 in cell-steroids that have a hormonal effect

Country Status (29)

Country Link
US (1) US7169769B2 (ko)
EP (1) EP1427748B1 (ko)
JP (1) JP4471653B2 (ko)
KR (1) KR100940054B1 (ko)
CN (1) CN1257913C (ko)
AR (1) AR036462A1 (ko)
AT (1) ATE395352T1 (ko)
AU (1) AU2002339536B2 (ko)
BR (1) BR0212409A (ko)
CA (1) CA2505575C (ko)
CY (1) CY1108152T1 (ko)
DE (1) DE60226623D1 (ko)
DK (1) DK1427748T3 (ko)
EC (1) ECSP045012A (ko)
ES (1) ES2305306T3 (ko)
HK (1) HK1063637A1 (ko)
HR (1) HRP20040193A2 (ko)
HU (1) HUP0402139A3 (ko)
IL (2) IL160451A0 (ko)
IS (1) IS2555B (ko)
MX (1) MXPA04002418A (ko)
NO (1) NO326624B1 (ko)
NZ (1) NZ531487A (ko)
PL (1) PL207493B1 (ko)
PT (1) PT1427748E (ko)
RU (1) RU2294332C2 (ko)
TW (1) TWI221154B (ko)
WO (1) WO2003022864A1 (ko)
ZA (1) ZA200401992B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
AU3162200A (en) * 1999-03-08 2000-09-28 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
US6905714B2 (en) * 2000-02-29 2005-06-14 National University Of Singapore Method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
ZA200401992B (en) 2005-04-21
BR0212409A (pt) 2004-08-03
IS2555B (is) 2009-10-15
CY1108152T1 (el) 2014-02-12
MXPA04002418A (es) 2004-07-30
PT1427748E (pt) 2008-08-27
HUP0402139A2 (hu) 2005-02-28
HUP0402139A3 (en) 2012-12-28
US20040259849A1 (en) 2004-12-23
HK1063637A1 (en) 2005-01-07
WO2003022864A1 (en) 2003-03-20
PL207493B1 (pl) 2010-12-31
NZ531487A (en) 2005-08-26
EP1427748B1 (en) 2008-05-14
ATE395352T1 (de) 2008-05-15
JP2005505566A (ja) 2005-02-24
CA2505575A1 (en) 2003-03-20
KR20040039346A (ko) 2004-05-10
NO20041010L (no) 2004-03-10
AU2002339536B2 (en) 2008-04-24
CA2505575C (en) 2010-01-26
PL368727A1 (en) 2005-04-04
DE60226623D1 (de) 2008-06-26
TWI221154B (en) 2004-09-21
HRP20040193A2 (en) 2004-08-31
RU2294332C2 (ru) 2007-02-27
NO326624B1 (no) 2009-01-19
EP1427748A1 (en) 2004-06-16
CN1257913C (zh) 2006-05-31
US7169769B2 (en) 2007-01-30
CN1553917A (zh) 2004-12-08
RU2004110934A (ru) 2005-08-20
ECSP045012A (es) 2004-09-27
AR036462A1 (es) 2004-09-08
KR100940054B1 (ko) 2010-02-04
DK1427748T3 (da) 2008-09-08
IS7165A (is) 2004-02-26
ES2305306T3 (es) 2008-11-01
IL160451A (en) 2009-11-18
JP4471653B2 (ja) 2010-06-02

Similar Documents

Publication Publication Date Title
TW595857U (en) 091219345
AU2002359464A8 (en) Angiopioetin related factors
IL160451A0 (en) 17 alpha-hydroxy-14beta-steroids with hormonal effect
GB0106031D0 (en) Use
GB0112267D0 (en) The pagekeeper
GB0124935D0 (en) The safetycom
GB0111630D0 (en) Unistore 800
GB0118315D0 (en) Jackit 31
GB0118917D0 (en) Biopower 3
TW539394U (en) 090212946
TW539396U (en) 090220607
GB0118177D0 (en) July 25
GB0118178D0 (en) July 24
GB0125582D0 (en) Fotwear designs 4
GB0113825D0 (en) The quitter
GB0124746D0 (en) The chopfast fingerguard
GB0100466D0 (en) The medi-disc
GB0107981D0 (en) The vac-groom
GB0108148D0 (en) The shock-stopper
GB0102763D0 (en) The foot-rocker
GB0115303D0 (en) The memopage
GB0120732D0 (en) The Fridgsaw
GB0121130D0 (en) The rollmaster
GB0121904D0 (en) The knobber
GB0121922D0 (en) The arrowmaker